case study Case study: Synthetic data for quality control in genomic pathology CSIRO’s Transformational Bioinformatics group creates a quality control pipeline for genomic pathology
Why GWAS matter? As technology improves and associated costs decrease DNA sequencing is becoming more prevalent in health care settings. DNA sequencing technologies are gaining relevance in the clinic because of its decreasing costs and the
